Sentences with phrase «litigation product liability litigation»

Commercial Litigation Product Liability Litigation - Defendants Product Liability Litigation - Plaintiffs

Discrimination Claims Employment Litigation Government / Public Entity Liability Insurance Bad Faith and Coverage Litigation Product Liability Litigation Professional Liability Litigation

Not exact matches

Important factors that could cause actual results to differ materially from those reflected in such forward - looking statements and that should be considered in evaluating our outlook include, but are not limited to, the following: 1) our ability to continue to grow our business and execute our growth strategy, including the timing, execution, and profitability of new and maturing programs; 2) our ability to perform our obligations under our new and maturing commercial, business aircraft, and military development programs, and the related recurring production; 3) our ability to accurately estimate and manage performance, cost, and revenue under our contracts, including our ability to achieve certain cost reductions with respect to the B787 program; 4) margin pressures and the potential for additional forward losses on new and maturing programs; 5) our ability to accommodate, and the cost of accommodating, announced increases in the build rates of certain aircraft; 6) the effect on aircraft demand and build rates of changing customer preferences for business aircraft, including the effect of global economic conditions on the business aircraft market and expanding conflicts or political unrest in the Middle East or Asia; 7) customer cancellations or deferrals as a result of global economic uncertainty or otherwise; 8) the effect of economic conditions in the industries and markets in which we operate in the U.S. and globally and any changes therein, including fluctuations in foreign currency exchange rates; 9) the success and timely execution of key milestones such as the receipt of necessary regulatory approvals, including our ability to obtain in a timely fashion any required regulatory or other third party approvals for the consummation of our announced acquisition of Asco, and customer adherence to their announced schedules; 10) our ability to successfully negotiate, or re-negotiate, future pricing under our supply agreements with Boeing and our other customers; 11) our ability to enter into profitable supply arrangements with additional customers; 12) the ability of all parties to satisfy their performance requirements under existing supply contracts with our two major customers, Boeing and Airbus, and other customers, and the risk of nonpayment by such customers; 13) any adverse impact on Boeing's and Airbus» production of aircraft resulting from cancellations, deferrals, or reduced orders by their customers or from labor disputes, domestic or international hostilities, or acts of terrorism; 14) any adverse impact on the demand for air travel or our operations from the outbreak of diseases or epidemic or pandemic outbreaks; 15) our ability to avoid or recover from cyber-based or other security attacks, information technology failures, or other disruptions; 16) returns on pension plan assets and the impact of future discount rate changes on pension obligations; 17) our ability to borrow additional funds or refinance debt, including our ability to obtain the debt to finance the purchase price for our announced acquisition of Asco on favorable terms or at all; 18) competition from commercial aerospace original equipment manufacturers and other aerostructures suppliers; 19) the effect of governmental laws, such as U.S. export control laws and U.S. and foreign anti-bribery laws such as the Foreign Corrupt Practices Act and the United Kingdom Bribery Act, and environmental laws and agency regulations, both in the U.S. and abroad; 20) the effect of changes in tax law, such as the effect of The Tax Cuts and Jobs Act (the «TCJA») that was enacted on December 22, 2017, and changes to the interpretations of or guidance related thereto, and the Company's ability to accurately calculate and estimate the effect of such changes; 21) any reduction in our credit ratings; 22) our dependence on our suppliers, as well as the cost and availability of raw materials and purchased components; 23) our ability to recruit and retain a critical mass of highly - skilled employees and our relationships with the unions representing many of our employees; 24) spending by the U.S. and other governments on defense; 25) the possibility that our cash flows and our credit facility may not be adequate for our additional capital needs or for payment of interest on, and principal of, our indebtedness; 26) our exposure under our revolving credit facility to higher interest payments should interest rates increase substantially; 27) the effectiveness of any interest rate hedging programs; 28) the effectiveness of our internal control over financial reporting; 29) the outcome or impact of ongoing or future litigation, claims, and regulatory actions; 30) exposure to potential product liability and warranty claims; 31) our ability to effectively assess, manage and integrate acquisitions that we pursue, including our ability to successfully integrate the Asco business and generate synergies and other cost savings; 32) our ability to consummate our announced acquisition of Asco in a timely matter while avoiding any unexpected costs, charges, expenses, adverse changes to business relationships and other business disruptions for ourselves and Asco as a result of the acquisition; 33) our ability to continue selling certain receivables through our supplier financing program; 34) the risks of doing business internationally, including fluctuations in foreign current exchange rates, impositions of tariffs or embargoes, compliance with foreign laws, and domestic and foreign government policies; and 35) our ability to complete the proposed accelerated stock repurchase plan, among other things.

Such risks, uncertainties and other factors include, without limitation: (1) the effect of economic conditions in the industries and markets in which United Technologies and Rockwell Collins operate in the U.S. and globally and any changes therein, including financial market conditions, fluctuations in commodity prices, interest rates and foreign currency exchange rates, levels of end market demand in construction and in both the commercial and defense segments of the aerospace industry, levels of air travel, financial condition of commercial airlines, the impact of weather conditions and natural disasters and the financial condition of our customers and suppliers; (2) challenges in the development, production, delivery, support, performance and realization of the anticipated benefits of advanced technologies and new products and services; (3) the scope, nature, impact or timing of acquisition and divestiture or restructuring activity, including the pending acquisition of Rockwell Collins, including among other things integration of acquired businesses into United Technologies» existing businesses and realization of synergies and opportunities for growth and innovation; (4) future timing and levels of indebtedness, including indebtedness expected to be incurred by United Technologies in connection with the pending Rockwell Collins acquisition, and capital spending and research and development spending, including in connection with the pending Rockwell Collins acquisition; (5) future availability of credit and factors that may affect such availability, including credit market conditions and our capital structure; (6) the timing and scope of future repurchases of United Technologies» common stock, which may be suspended at any time due to various factors, including market conditions and the level of other investing activities and uses of cash, including in connection with the proposed acquisition of Rockwell; (7) delays and disruption in delivery of materials and services from suppliers; (8) company and customer - directed cost reduction efforts and restructuring costs and savings and other consequences thereof; (9) new business and investment opportunities; (10) our ability to realize the intended benefits of organizational changes; (11) the anticipated benefits of diversification and balance of operations across product lines, regions and industries; (12) the outcome of legal proceedings, investigations and other contingencies; (13) pension plan assumptions and future contributions; (14) the impact of the negotiation of collective bargaining agreements and labor disputes; (15) the effect of changes in political conditions in the U.S. and other countries in which United Technologies and Rockwell Collins operate, including the effect of changes in U.S. trade policies or the U.K.'s pending withdrawal from the EU, on general market conditions, global trade policies and currency exchange rates in the near term and beyond; (16) the effect of changes in tax (including U.S. tax reform enacted on December 22, 2017, which is commonly referred to as the Tax Cuts and Jobs Act of 2017), environmental, regulatory (including among other things import / export) and other laws and regulations in the U.S. and other countries in which United Technologies and Rockwell Collins operate; (17) the ability of United Technologies and Rockwell Collins to receive the required regulatory approvals (and the risk that such approvals may result in the imposition of conditions that could adversely affect the combined company or the expected benefits of the merger) and to satisfy the other conditions to the closing of the pending acquisition on a timely basis or at all; (18) the occurrence of events that may give rise to a right of one or both of United Technologies or Rockwell Collins to terminate the merger agreement, including in circumstances that might require Rockwell Collins to pay a termination fee of $ 695 million to United Technologies or $ 50 million of expense reimbursement; (19) negative effects of the announcement or the completion of the merger on the market price of United Technologies» and / or Rockwell Collins» common stock and / or on their respective financial performance; (20) risks related to Rockwell Collins and United Technologies being restricted in their operation of their businesses while the merger agreement is in effect; (21) risks relating to the value of the United Technologies» shares to be issued in connection with the pending Rockwell acquisition, significant merger costs and / or unknown liabilities; (22) risks associated with third party contracts containing consent and / or other provisions that may be triggered by the Rockwell merger agreement; (23) risks associated with merger - related litigation or appraisal proceedings; and (24) the ability of United Technologies and Rockwell Collins, or the combined company, to retain and hire key personnel.

Many factors could cause BlackBerry's actual results, performance or achievements to differ materially from those expressed or implied by the forward - looking statements, including, without limitation: BlackBerry's ability to enhance its current products and services, or develop new products and services in a timely manner or at competitive prices, including risks related to new product introductions; risks related to BlackBerry's ability to mitigate the impact of the anticipated decline in BlackBerry's infrastructure access fees on its consolidated revenue by developing an integrated services and software offering; intense competition, rapid change and significant strategic alliances within BlackBerry's industry; BlackBerry's reliance on carrier partners and distributors; risks associated with BlackBerry's foreign operations, including risks related to recent political and economic developments in Venezuela and the impact of foreign currency restrictions; risks relating to network disruptions and other business interruptions, including costs, potential liabilities, lost revenues and reputational damage associated with service interruptions; risks related to BlackBerry's ability to implement and to realize the anticipated benefits of its CORE program; BlackBerry's ability to maintain or increase its cash balance; security risks; BlackBerry's ability to attract and retain key personnel; risks related to intellectual property rights; BlackBerry's ability to expand and manage BlackBerry ® World ™; risks related to the collection, storage, transmission, use and disclosure of confidential and personal information; BlackBerry's ability to manage inventory and asset risk; BlackBerry's reliance on suppliers of functional components for its products and risks relating to its supply chain; BlackBerry's ability to obtain rights to use software or components supplied by third parties; BlackBerry's ability to successfully maintain and enhance its brand; risks related to government regulations, including regulations relating to encryption technology; BlackBerry's ability to continue to adapt to recent board and management changes and headcount reductions; reliance on strategic alliances with third - party network infrastructure developers, software platform vendors and service platform vendors; BlackBerry's reliance on third - party manufacturers; potential defects and vulnerabilities in BlackBerry's products; risks related to litigation, including litigation claims arising from BlackBerry's practice of providing forward - looking guidance; potential charges relating to the impairment of intangible assets recorded on BlackBerry's balance sheet; risks as a result of actions of activist shareholders; government regulation of wireless spectrum and radio frequencies; risks related to economic and geopolitical conditions; risks associated with acquisitions; foreign exchange risks; and difficulties in forecasting BlackBerry's financial results given the rapid technological changes, evolving industry standards, intense competition and short product life cycles that characterize the wireless communications industry.

Daniel Campbell is an associate at McDermott Will & Emery where he focuses on commercial litigation matters, including collective and class actions and products liability actions.

Important factors that could cause actual results to differ materially from those expressed or implied by such forward - looking statements include, without limitation, possible product defects and product liability, risks related to international sales and potential foreign currency exchange fluctuations, the initiation or outcome of litigation, acts or potential acts of terrorism, international conflicts, significant fluctuations of quarterly operating results, changes in Canadian and foreign laws and regulations, continued acceptance of RIM's products, increased levels of competition, technological changes and the successful development of new products, dependence on third - party networks to provide services, dependence on intellectual property rights, and other risks and factors detailed from time to time in RIM's periodic reports filed with the United States Securities and Exchange Commission, and other regulatory authorities.

About Blog This publication offers insight and commentary regarding the defense of pharmaceutical and medical device product liability litigation.

About Blog This publication offers insight and commentary regarding the defense of pharmaceutical and medical device product liability litigation.

Spring, 2010 — ABA Section of Litigation, Products Liability Litigation Committee, Products Liability, Vol 21, No. 2, Social Media and the CPSIA: Lessons Learned from Mr. Squiggles (print version); The CPSIA and Social Media Make Product Issues Public (online version)

Related Categories: 9th Circuit Court States Consumer Law Product Liability Law Trials & Litigation Injury & Accident Law Legislation & Lobbying Tort Law California Partner Verdicts & Settlements

Product liability litigation is often the preserve of plaintiff class action lawyers and large Bay Street defence firms, not Main Street law firms.

He works in law firm Wiggin & Dana's litigation department with a practice focused on product liability and aviation litigation, amusement / leisure counseling and litigation, and general business litigation.

Second, and most important, motor vehicle litigation will move from a system where accidents are assessed based on driver negligence to a products liability system, where manufacturers bear more of the burden for failure of things such as sensors and warning systems.

Practice Areas: Litigation, Civil Litigation Law, Personal Injury Defense Law, Toxic Torts Law, Asbestos Defense Law, Environmental Law, Product Liability Law, Construction Law, Construction Defects Law, Asbestos Litigation Law

Paul Maloney is a trial lawyer who focuses his practice in product liability, professional liability, and commercial litigation.

The company said that the reason they're being forced to close - up shop is product liability litigation.

Mr. Leopold specializes in consumer justice litigation with a focus on complex products liability, managed care, catastrophic injury and class action litigation.

Harlan Prater's three decades of law practice have been devoted to all types of high - stakes civil trial work, with a focus on product liability and pharmaceutical and medical device litigation.

Brandon concentrates his practice in general civil litigation matters; including premises liability, product liability, construction and various insurance defense cases.

Among his other distinctions, Stewart has been recognized by The Best Lawyers in America for the areas of Medical Malpractice Law (2013 — present), Personal Injury Litigation (2014 — present) and Product Liability Litigation (2016 — present).

Will is a shareholder, member of the Litigation Group, and co-chair of our Construction Litigation and Products Liability teams.

He was recently named a 2018 Best Lawyers in America «Lawyer of the Year» in the practice area of Product Liability Litigation — Plaintiffs in West Palm Beach for his expertise.

Practice Areas: Health Care Professional Malpractice Product Liability Commercial Litigation

The L.A. office opens with strong capabilities in areas including cyber risk, sports and entertainment, and complex product liability litigation, and will expand to cover the firm's full set of capabilities spanning all areas of civil litigation, corporate transactions, regulatory compliance, and risk - avoidance counsel.

Harlan Prater has devoted his career to all types of high - stakes civil trial work, with a focus on product liability and pharmaceutical and medical device litigation.

Steven Vahidi will join the firm's Product Liability, Class Action Litigation, and Transportation Practice Groups.

He practices general litigation, including construction defect, product liability, and personal injury matters.

John has served as an expert witness regarding issues in asbestos litigation; he is a frequent speaker and commentator on products liability litigation; and he has coordinated clients» lobbying efforts in the U.S. House and Senate to create national asbestos legislation.

Brendan has acted on a wide range of insurance and reinsurance matters for Australian - based and international clients, including flooding, storm, earthquake, fire and explosion events, electricity supply issues and machinery break - downs, as well as high - value class action litigation, public and product liability, and subrogation claims.

Andi is an experienced litigator focusing her practice on complex commercial litigation, including shareholder and corporate governance disputes, fraud, RICO, land use, construction, shareholder derivative suits, business torts, supply chain, class actions, product liability, trade secrets and non-compete disputes.

Stephen has a broad civil litigation practice with extensive experience in breach of trust claims, commercial disputes, construction liens, construction and environmental liability claims, First Nations consultation rights in land development, insurance coverage, product liability, professional liability and subrogation.

Wynn Shuford recently offered guidance on dealing with these «Litigation Landmines» at the 2013 Fall Conference of the Product Liability Advisory Council in Las Vegas, Nevada.

To date, Tom has been lead counsel in over 100 jury trials in both Federal and State Court encompassing a wide variety of injuries and wrongful death resulting from product liability, premises liability, vehicular, trucking accidents, and bad faith litigation.

She focuses her practice on complex business litigation and arbitration, including class action defense, breach of contract, product liability, and fraud.

Levy, now a member in Eckert's Philadelphia office, has a broad litigation practice covering product liability, commercial litigation, risk management, and white - collar criminal defense.

With more than 40 years of experience, James is a Florida Bar Board Certified Specialist in Civil Trial law with extensive experience in handling high - risk cases and regional litigation management in commercial, drug & medical device and product liability cases.

Managing Partner Theodore J. Leopold specializes in consumer justice litigation with a focus on complex products liability, managed care, catastrophic injury and class action litigation.

Product liability for medications that cause injury is also known as pharmaceutical litigation when the manufacturer produces a defective drug.

Lana Olson focuses her practice on complex, high - stakes litigation in a variety of areas, including environmental and toxic tort, product liability, employment and catastrophic injury.

He practices in the Litigation Department with the Health Law and Products and General Liability practice groups.

At the Lynn Law Firm, he brings this broad experience and unique strategic perspective to represent clients in personal injury, insurance coverage, products liability, contract disputes, antitrust / intellectual property, and other civil litigation matters.

Her principal areas of practice include employment law, professional licensing, insurance coverage, bad faith litigation, product liability, medical malpractice defense, and commercial litigation.

Although my main focus area is on insurance defense litigation, particularly motor vehicle negligence, construction defect litigation, and professional malpractice, I also have experience in business & commercial litigation, patent / trademark / copyright law, trade secrets infringement, and premises / product liability.

Main areas of work The firm's main areas of practice include business and commercial litigation, corporate, criminal defense, employment and labor law, financial restructuring and creditors» rights, government affairs, intellectual property, products liability and real property and environmental.

Mr. Leopold lectures frequently at professional gatherings on such issues as personal injury, product liability, class action litigation, trial tactics and consumer justice.

Prior to joining the firm, Cari represented national companies in litigation for claims involving healthcare, personal injury, contract disputes, and product liability matters.

Described as a «reliable partner providing an excellent service level», Hogan Lovells International LLP handles a broad range of contentious matters including commercial, corporate and contractual litigation and is particularly well versed in product liability.

Professional Associations Monroe County Bar Association, Member New York State Bar Association, Chairman: Torts, Insurance, and Compensation Law Section (2003 - 2004) NYSBA Automobile Liability Committee Chairman (1991 - 1995) NYSBA House of Delegates, Delegate (1999 - 2004) New York State Trial Lawyers Association Risk and Insurance Management Society (2007 - present) Council on Litigation Management (2008 - present); Chairman, Products Liability Conference (2010 - 2013) New York Editorial Board, Lawyers Cooperative Publishing Company (1993 - 1995) Defense Research Institute (2000 - present) The National Fire Protection Association, Member The American Society for Metals, Member

Mr. Amantea focuses his practice on environmental, transactional and judicial proceedings, as well as product liability claims and other complex litigation.